Fsd Pharma (TSE:HUGE) has released an update.
FSD Pharma Inc., a biopharmaceutical company, announces the expansion of its research pipeline with a focus on developing new products aimed at weight loss and liver health. Building on its portfolio of solutions for neurodegenerative and metabolic disorders, the company explores ingredients for potential dietary supplements to promote liver health and reduce visceral fat. This expansion includes potential additions to FSD Pharma’s product line beyond their current offering, unbuzzd™, designed to aid in faster alcohol metabolism.
For further insights into TSE:HUGE stock, check out TipRanks’ Stock Analysis page.
